rhodamine 123 has been researched along with Duncan Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Domnikova, NP; Grishanova, AY; Lyakhovich, VV; Melnikova, EV; Mukhin, OV; Vorontsova, EV | 1 |
Iwasaki, T; Kobayashi, Y; Naito, M; Oshimi, K; Tsuruo, T; Watanabe, N; Yamamoto, T | 1 |
Amiot, L; Drénou, B; Fauchet, R; Lamy, T; Le Prisé, PY | 1 |
3 other study(ies) available for rhodamine 123 and Duncan Disease
Article | Year |
---|---|
Functional activity of P-glycoprotein in lymphocytes of patients with lymphoproliferative diseases.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Case-Control Studies; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Lymphocytes; Lymphoproliferative Disorders; Rhodamine 123 | 2003 |
Expression of multidrug resistance P-glycoprotein on peripheral blood mononuclear cells of patients with granular lymphocyte-proliferative disorders.
Topics: Adult; Aged; Antigens, CD; ATP Binding Cassette Transporter, Subfamily B, Member 1; CD5 Antigens; Drug Resistance; Female; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Humans; Leukocytes, Mononuclear; Lymphoproliferative Disorders; Male; Membrane Glycoproteins; Middle Aged; Rhodamine 123; Rhodamines; T-Lymphocytes | 1993 |
Multidrug resistance in aggressive lymphoproliferative disorders of T and natural-killer origin.
Topics: Antigens, CD; Drug Resistance, Multiple; Fluorescent Dyes; Humans; Immunophenotyping; Killer Cells, Natural; Lymphoma, Non-Hodgkin; Lymphoproliferative Disorders; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Rhodamine 123; Rhodamines; T-Lymphocytes | 1998 |